[Form 4] PubMatic, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Rajeev K. Goel, PubMatic, Inc. CEO, director and reported ~10% owner, filed a Form 4 reporting transactions dated 09/02/2025. The filing shows an acquisition entry of 44,000 shares of Class A common stock (non-derivative) and a sale of 44,000 shares at a weighted-average price of $8.4484, with the sale effected pursuant to a Rule 10b5-1 trading plan adopted March 2, 2025.
The report discloses related transfers of shares to The Goel Family Trust and notes that following the reported sales Mr. Goel holds 2,362,194 shares of Class A and Class B common stock (excluding unvested/vested-but-unexercised option amounts). The filing also records option activity: 44,000 options with a $1.11 exercise price that are fully vested and expire on 07/07/2026. The form is signed by an attorney-in-fact on 09/04/2025.
Positive
- Use of a Rule 10b5-1 trading plan for the sales, indicating transactions were pre-arranged and not opportunistic
- Clear disclosure of post-transaction beneficial ownership (2,362,194 shares) and option expiry date (07/07/2026)
- Footnotes explain transfers to family trusts and disclaimers of beneficial ownership where applicable, enhancing transparency
Negative
- Disposition of 44,000 shares was executed, resulting in realized sales at a weighted-average price of $8.4484
- Transfers to related trusts and subsequent sales may create perceived insider liquidity despite being under a 10b5-1 plan
Insights
TL;DR: Insider exercise and subsequent sale under a 10b5-1 plan; modest realized proceeds at ~$8.45 average price.
The filing documents an option exercise/related conversion and the sale of 44,000 shares at a weighted-average price of $8.4484, executed under a pre-established Rule 10b5-1 plan. The disclosure clarifies post-transaction beneficial ownership of 2,362,194 shares, excluding unvested awards. For analysts, this is routine insider liquidity rather than an unplanned disposal: the use of a 10b5-1 plan and transfers to a family trust indicate pre-arranged execution and planning. The reported option batch is fully vested and expires 07/07/2026, which may influence potential future share supply if exercised and sold.
TL;DR: Proper disclosure of exercised options, trust transfers and Rule 10b5-1 sales; governance procedures appear followed.
The Form 4 includes detailed footnotes describing transfers to family trusts, disclaimers of beneficial ownership for certain trust-held shares, and explicit statement that the sales were effected pursuant to a 10b5-1 trading plan adopted 03/02/2025. The report also provides the weighted-average sale price range and offers to furnish per-price sale details upon request, which supports transparency. Signature by an attorney-in-fact is properly disclosed. From a governance perspective, the filing adheres to Section 16 reporting norms and documents pre-planned insider trading safeguards.